reports
Correction: Director/PDMR Shareholding
Correction: Director/PDMR Shareholding Volta Finance Limited (VTA/VTAS) Notification of transactions by directors, persons discharging managerial responsibilities and persons closely associated with them NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES ***** Guernsey, 2 May 2025 Pursuant to the announcements made on 5 April 2019 and 26 June 2020 relating to changes to the payment of directors fees, Volta Finance Limited (the “Company” or “Volta”) has purchased 3,307 ordinary shares of no par value in the Company (“Ordinary Shares”) at an a...
Director/PDMR Shareholding
Director/PDMR Shareholding Volta Finance Limited (VTA/VTAS) Notification of transactions by directors, persons discharging managerial responsibilities and persons closely associated with them NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES ***** Guernsey, 2 May 2025 Pursuant to the announcements made on 5 April 2019 and 26 June 2020 relating to changes to the payment of directors fees, Volta Finance Limited (the “Company” or “Volta”) has purchased 3,307 ordinary shares of no par value in the Company (“Ordinary Shares”) at an average price...
- Brian Moretta
- Jason Streets
- Mark Thomas
Hardman & Co Monthly: May 2025
Feature article: Attractive asset managers - Radical derating presumes things only get worse The UK asset management sector has been significantly derated over the past couple of years. It has faced the dual problem of a shift towards passives and to private assets and away from traditional listed equities and bonds. However, the sector’s assets haven’t collapsed; its margins have proved relatively robust and its profits fairly stable, even against all the rising costs. The clear implication, ...
Volta Finance Limited - Net Asset Value(s) as at 31 March 2025
Volta Finance Limited - Net Asset Value(s) as at 31 March 2025 Volta Finance Limited (VTA / VTAS)March 2025 monthly reportNOT FOR RELEASE, DISTRIBUTION, OR PUBLICATION, IN WHOLE OR PART, IN OR INTO THE UNITED STATES Guernsey, April 23rd, 2025 AXA IM has published the Volta Finance Limited (the “Company” or “Volta Finance” or “Volta”) monthly report for March 2025. The full report is attached to this release and will be available on Volta’s website shortly (). Performance and Portfolio Activity Dear Investors, Volta Finance’s net performance for the month of March was negative -2.9%, ta...
Directorate change
Directorate change Volta Finance Limited (VTA/VTAS) Directorate Changes NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES Guernsey, 2 April 2025 Appointment of new director The Board of Volta Finance Limited (“the Board”) is pleased to announce the appointment of Mr Simon Holden as an independent non-executive director, with effect from 1 June 2025. Mr Simon Holden, Chartered Director (CDir) and Fellow of the Institute of Directors, brings a combination of private equity investing and deep equity capital markets experience to the Boar...
Half-year report
Half-year report Volta Finance Limited (VTA/VTAS) Publication of the Half-Yearly Financial Reportfor the period from 1 August 2024 to 31 January 2025 NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, IN OR INTOTHE UNITED STATES *****Guernsey, 2 April 2025 Volta Finance Limited has published its results for the six month period ended 31 January 2025. The half-yearly financial report is attached to this release and will be available on Volta Finance Limited's website shortly () and will be uploaded to the National Storage Mechanism. CONTACTSFor the Investment ManagerAX...
- Mark Thomas
- Martin Hall
Hardman & Co Monthly: April 2025
Feature article: 2024 pharma statistics An efficient reporting system has seen all the listed multinational pharmaceutical companies announce results for 2024, which has given us the opportunity to update our industry statistics and drug database. This report provides the first snapshot of global pharmaceutical market growth plus the global and US company rankings for 2024. The year was characterised by 9.2% underlying (ex-COVID-19) growth. Much of the growth was driven by recently launched ant...
Volta Finance Limited - Net Asset Value(s) as at 28 February 2025
Volta Finance Limited - Net Asset Value(s) as at 28 February 2025 Volta Finance Limited (VTA / VTAS)February 2025 monthly reportNOT FOR RELEASE, DISTRIBUTION, OR PUBLICATION, IN WHOLE OR PART, IN OR INTO THE UNITED STATES Guernsey, March 21st, 2025 AXA IM has published the Volta Finance Limited (the “Company” or “Volta Finance” or “Volta”) monthly report for February 2025. The full report is attached to this release and will be available on Volta’s website shortly (). Performance and Portfolio Activity Dear Investors, Volta Finance’s net performance for the month of February establishe...
Volta Finance Limited - Dividend Declaration
Volta Finance Limited - Dividend Declaration Volta Finance Limited (VTA/VTAS) Dividend Declaration NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES Guernsey, 5 March 2025 Volta Finance Limited ("the Company") hereby announces that it has declared a quarterly interim dividend of €0.155 per share payable on 3 April 2025 amounting to approximately €5.67 million, approximately equating to an annualised 8% of net asset value. The ex-dividend date is 13 March 2025 with a record date of 14 March 2025. The Company has arranged for its sharehold...
- Mark Thomas
- Nigel Hawkins
Hardman & Co Monthly: March 2025
In this month's feature article, we review the energy situation in the UK. On the domestic front, Ofgem has recently announced the new price cap figure of £1,849 for a typical household’s annual use of gas and electricity; this figure represents an increase of 6.4% over the January-March 2025 price cap. UK energy policy has changed of late, following the election of a Labour government last summer. The quest for Net Zero by 2030 – a hardly realistic target – is now a priority. Rightly or wrong...
Hardman & Co Q&A on Volta Finance Ltd (VTAS): Can 2025 outshine a stel...
Hardman & Co Research Hardman & Co Q&A on Volta Finance Ltd (VTAS): Can 2025 outshine a stellar 2024 performance? 26-Feb-2025 / 12:20 GMT/BST The issuer is solely responsible for the content of this announcement. Analyst interview | Investment Companies Q&A on Volta Finance Ltd | Can 2025 outshine a stellar 2024 performance? Volta Finance Ltd (LON:VTA,VTAS) delivered impressive returns in 2024, significantly outperforming comparable asset classes. In this interview, Mark Thomas, analyst at Hardman & Co, highlights the key drivers behind Volta’s recent success and outlines ...
Net Asset Value(s) as at 31 January 2025
Net Asset Value(s) as at 31 January 2025 Volta Finance Limited (VTA / VTAS)January 2025 monthly reportNOT FOR RELEASE, DISTRIBUTION, OR PUBLICATION, IN WHOLE OR PART, IN OR INTO THE UNITED STATES Guernsey, February 20th, 2025 AXA IM has published the Volta Finance Limited (the “Company” or “Volta Finance” or “Volta”) monthly report for January 2025. The full report is attached to this release and will be available on Volta’s website shortly (). Performance and Portfolio Activity Dear Investors, Volta Finance started 2025 on a positive note as net performance reached +1.7% in January wh...
Hardman & Co Research on Volta Finance Limited (VTAS): 2024 experience...
Hardman & Co Research Hardman & Co Research on Volta Finance Limited (VTAS): 2024 experience bodes well for 2025 17-Feb-2025 / 07:15 GMT/BST The issuer is solely responsible for the content of this announcement. Hardman & Co Research | Closed End Investments Volta Finance Limited (VTAS) | 2024 experience bodes well for 2025 Volta has delivered +21.2% 2024 total NAV return, outperforming i) B-rated CLO tranches (+19.2%), ii) US high yield (+8.2%), iii) Euro high yield (+8.6%), and iv) global loans (+7.3%). Its performance reflects positive markets and the incremental value ad...
- Mark Thomas
Volta Finance Limited (VTAS): 2024 experience bodes well for 2025
Volta has delivered +21.2% 2024 total NAV return, outperforming i) B-rated CLO tranches (+19.2%), ii) US high yield (+8.2%), iii) Euro high yield (+8.6%), and iv) global loans (+7.3%). Its performance reflects positive markets and the incremental value added by the manager through its asset selection and portfolio management. Looking into 2025, we expect another strong year from CLOs: more market growth (partially driven by loans issued to fund greater PE activity), and stable, if not falling, d...
Volta Finance Limited - Director/PDMR Shareholding
Volta Finance Limited - Director/PDMR Shareholding Volta Finance Limited (VTA/VTAS) Notification of transactions by directors, persons discharging managerial responsibilities and persons closely associated with them NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES ***** Guernsey, 3 February 2025 Pursuant to the announcements made on 5 April 2019 and 26 June 2020 relating to changes to the payment of directors fees, Volta Finance Limited (the “Company” or “Volta”) has purchased 3,250 ordinary shares of no par value in the Company (“Ordinary...
- Keith Hiscock
- Mark Thomas
Hardman & Co Monthly: February 2025
Feature article: The October 2024 Budget - We got it wrong By Keith Hiscock, CEO at Hardman & Co In this month's feature article, we review the effects of the 2024 Budget and consider what might happen in the coming months. Our Hardman Monthly of October 2024 looked forward to the first Labour Budget for 14 years. The main theme was that, because the new Chancellor, Rachel Reeves, had ruled out increases in taxes on ‘working people’, investors would bear the brunt of any tax increases to fill ...
Volta Finance Limited - Net Asset Value as at 31 December 2024
Volta Finance Limited - Net Asset Value as at 31 December 2024 Volta Finance Limited (VTA / VTAS)December 2024 monthly reportNOT FOR RELEASE, DISTRIBUTION, OR PUBLICATION, IN WHOLE OR PART, IN OR INTO THE UNITED STATES Guernsey, January 22th, 2025 AXA IM has published the Volta Finance Limited (the “Company” or “Volta Finance” or “Volta”) monthly report for December 2024. The full report is attached to this release and will be available on Volta’s website shortly (). Performance and Portfolio Activity Dear Investors, Volta Finance achieved a net performance of +0.3% in the final month ...
Volta Finance Limited: 1 director
A director at Volta Finance Limited bought 19,000 shares at 6.079EUR and the significance rating of the trade was 74/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...
Volta Finance Limited: Director/PDMR Shareholding
Volta Finance Limited: Director/PDMR Shareholding 17 January 2025 Volta Finance Limited (the “Company”) Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons On 17 January 2025, Ms Dagmar Kershaw, (Chair of the the Company), purchased 19,000 Ordinary Euro shares in the Company. The below notification, made in accordance with the requirements of article 19.3 of the UK Market Abuse Regulation, gives further details: 1 Details of the person discharging managerial responsibilities / person closely associated a) Name 1) Dagmar...
- Brian Moretta
- Mark Thomas
- Martin Hall
Hardman & Co Monthly: January 2025
Feature article: Hardman & Co Healthcare Index, 2024 – Tough year for Life Sciences By Dr Martin Hall The main function of the HHI is to monitor the performance, and to highlight the attractiveness, of life sciences investments over the long term, and to try to identify those stocks that have disruptive technologies that consistently allow them to outperform both the index and the markets. Many of the 53 constituents of the index are high-risk, with micro-capitalisations and a long way from pro...
AGL ANGLE PLC
DEMG DELTEX MEDICAL GROUP PLC
TSTL TRISTEL PLC
TRX TISSUE REGENIX GROUP
EKF EKF DIAGNOSTICS HOLDINGS
ODX OMEGA DIAGNOSTICS
AVCT AVACTA GROUP
PHP PRIMARY HEALTH PROPERTIES PLC
AGY ALLERGY THERAPEUTICS PLC
ARBB ARBUTHNOT BANKING GROUP
APH ALLIANCE PHARMA PLC
FUM FUTURA MEDICAL PLC
ALNOV NOVACYT SAS
VLG VENTURE LIFE GROUP
RECI REAL ESTATE CREDIT INVESTMENTS
IMM IMMUPHARMA
PRM PROTEOME SCIENCES PLC
ACSO ACCESSO TECHNOLOGY GROUP
GNS GENUS PLC
SUN SURGICAL INNOVATIONS GROUP PLC
AMS ADVANCED MEDICAL SOLUTIONS GROUP PLC
OMG OXFORD METRICS
EAH ECO ANIMAL HEALTH GROUP
JDG JUDGES SCIENTIFIC
VTAS VOLTA FINANCE (GBP)
SDI SDI GROUP
HVO HVIVO
INDV INDIVIOR PLC
VAL VALIRX
FARON FARON PHARMACEUTICALS OY
ONC ONCIMMUNE HOLDINGS
STX SHIELD THERAPEUTICS
CSN CHESNARA PLC
SNG SYNAIRGEN PLC
IPO IP GROUP
HAT H&T GROUP
SCLP SCANCELL HOLDINGS
SYNC SYNCONA
CIR CIRCASSIA GROUP
SPI SPIRE HEALTHCARE GROUP PLC
AGR ASSURA PLC
APAX APAX GLOBAL ALPHA
ICGT ICG ENTERPRISE TRUST
GDR GENEDRIVE
CTEC CONVATEC GROUP PLC
CREO CREO MEDICAL GROUP
SBTX SKINBIOTHERAPEUTICS
A0MXLB NB PRIVATE EQUITY PARTNERS
FAB FUSION ANTIBODIES
IXI IXICO
OXB OXFORD BIOMEDICA PLC
ABDX ABINGDON HEALTH
IMCR IMMUNOCORE HOLDINGS ADS
POLX POLAREAN IMAGING
AREC ARECOR THERAPEUTICS
ONT OXFORD NANOPORE TECHNOLOGIES PLC
SLN SILENCE THERAPEUTICS PLC
SAR SAREUM HOLDINGS PLC
BAI BENEVOLENTAI
4BB 4BASEBIO PLC
TISSUE REGENIX GROUP PLC
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.